Vertex Pharmaceuticals Inc at JPMorgan Healthcare Conference (Virtual) Transcript
All right. Good morning, and once again, welcome to the 39th annual and first, and hopefully, only time, Virtual JPMorgan Healthcare Conference. My name is Cory Kasimov. I'm a senior large-cap biotech analyst, and it's my pleasure to introduce our next company, Vertex. And CEO, Reshma Kewalramani.
Please note that this -- after the presentation, we will have a Q&A session right here in the same Zoom room. (Operator Instructions) And if it's easier, you can also e-mail me questions as well, and I'll be monitoring my inbox.
So with that, let me turn things over to you, Reshma.
All right. Great. Thanks so much, Cory. Good morning all. Despite the very different format and the inability to see any of you, I'm really pleased to be here today and excited to share a preview of where we're headed in 2021 and beyond.
We're poised to deliver continued
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |